Evidence map›Paper›PMID 29616501›Full record

ReviewJournal of Zhejiang University. Science. B

Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens.

Warren Chanda, Thomson P Joseph, Xue-Fang Guo, Wen-Dong Wang, Min Liu, Miza S Vuai, Arshad A Padhiar, Min-Tao Zhong

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of Zhejiang University. Science. B. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04345809 (Effect of Prophylactic Prosthesis Placement With Versus Without Omega-3 at the Umbilical Trocar Level on Surgical Site Infection and Herniation After Laparoscopic Cholecystectomy in Patients With Risk Factors.), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04345809 completednot on this map

Effect of Prophylactic Prosthesis Placement With Versus Without Omega-3 at the Umbilical Trocar Level on Surgical Site Infection and Herniation After Laparoscopic Cholecystectomy in Patients With Risk Factors.

TypeobservationalSponsorFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaRan2016 to 2018Enrolled95ConditionsSurgical Site InfectionArmsMESH WHIT OMEGA-3, MESH WITHOUT OMEGA-3
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antimicrobial Activity ofInternational journal of molecular sciences · 2024
    Review
  11. Review
  12. Review
  13. Marine MicroalgaeCurrent pharmaceutical biotechnology · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Warren ChandaDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Thomson P JosephDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Xue-Fang GuoDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Wen-Dong WangDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Min LiuDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Miza S VuaiDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Arshad A PadhiarDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Min-Tao ZhongDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microorganisms provide both beneficial and harmful effects to human beings. Beneficial effects come from the symbiotic relationship that exists between humans and microbiota, but then several human illnesses have turned some friendly microbes into opportunistic pathogens, causing several microbial-related diseases. Various efforts have been made to create and utilize antimicrobial agents in the treatment and prevention of these infections, but such efforts have been hampered by the emergence of antimicrobial resistance. Despite extensive studies on drug discovery to alleviate this problem, issues with the toxicity and tolerance of certain compounds and continuous microbial evolution have forced researchers to focus on screening various phytochemical dietary compounds for antimicrobial activity. Linolenic acid and its derivatives (eicosapentaenoic acid and docosahexaenoic acid) are omega-3 fatty acids that have been studied due to their role in human health, being important for the brain, the eye, the cardiovascular system, and general human growth. However, their utilization as antimicrobial agents has not been widely appreciated, perhaps due to a lack of understanding of antimicrobial mechanisms, toxicity, and route of administration. Therefore, this review focuses on the efficacy, mechanism, and toxicity of omega-3 fatty acids as alternative therapeutic agents for treating and preventing diseases associated with pathogenic microorganisms.

Indexed as

alpha-Linolenic AcidAnimalsAnimals, Genetically ModifiedAnti-Infective AgentsAntioxidantsBacterial InfectionsCell MembraneClinical Trials as TopicDocosahexaenoic AcidsDrug Resistance, BacterialEicosapentaenoic AcidFatty Acids, Omega-3FishesHumansLipidsMicealpha-Linolenic AcidAnti-Infective AgentsAntioxidantsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3LipidsLinolenic acid; Omega-3 fatty acid; Eicosapentaenoic acid (EPA); Docosahexaenoic acid (DHA); Antimicrobial agent; Fatty acid

Identifiers

PMID29616501
PMCPMC5964344
OpenAlexW2800034390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.